NCT00649649

Food Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg

Single-Dose Food In Vivo Bioequivalence Study of Quinapril Hydrochloride Tablets (40 mg; Mylan) and Accupril® Tablets (40 mg; Parke-Davis) in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Mylan Pharmaceuticals Inc · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The objective of this study was to investigate the bioequivalence of Mylan quinapril hydrochloride 40 mg tablets compared to Parke-Davis Accupril® 40 mg tablets following a single, oral 40 mg (1 x 40 mg) dose under fed conditions.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Quinapril Hydrochloride Tablets 40 mg	40mg, single dose fed
DRUG	Accupril® Tablets 40 mg	40mg, single dose fed

Timeline

• Start date: 2002-12-01
• Primary completion: 2002-12-01
• Completion: 2003-01-01
• First posted: 2008-04-01
• Last updated: 2024-04-24

Locations

1 site across 1 country: United States